Pharma Journalist -

CytoReason announced that it has entered into a collaboration agreement with Pfizer that will leverage CytoReason’s cell-centered models of the immune system. CytoReason will receive…
Read More...

SMi presents its 13th annual Parallel Trade conference happening next month. The highly anticipated event provides the perfect platform for industry experts to come together and share…
Read More...

GE Healthcare and Vanderbilt University Medical Center (VUMC) announced a five-year partnership to enable safer and more precise cancer immunotherapies. Multiple diagnostic tools will…
Read More...

AmpliPhi Biosciences Corporation and C3J Therapeutics announced that the companies have entered into a definitive agreement under which a wholly owned subsidiary of AmpliPhi will merge…
Read More...

Personal invitations were sent in December 2018 from the conference chairman Mr James Drinkwater, for the 2nd Annual Pharmaceutical Microbiology East Coast Conference, taking place in…
Read More...

SMi Report: An exclusive interview with Marine Marius, Scientist, Analytical Research and Development Europe, Sanofi Pasteur just ahead of the 8th Annual Pharmaceutical Microbiology UK…
Read More...

Recipharm announces that it will initiate a process to explore the discontinuance of operations at its solid dose manufacturing facility in Ashton-under-Lyne, UK. The decision to…
Read More...

Merck KGaA, Darmstadt, Germany announced that through its wholly owned subsidiary, Ares Trading, it has evolved its agreement with Intrexon Corporation for the development of Chimeric…
Read More...

Eli Lilly and Company and Aduro Biotech, Inc. announced a research collaboration and exclusive license agreement for Aduro's cGAS-STING Pathway Inhibitor program for the research and…
Read More...

Gilead Sciences and Agenus Inc. announced the companies have entered into an immuno-oncology (I-O) partnership focused on the development and commercialization of up to five novel…
Read More...